DP

Discovery Park Ventures

North America, Washington, United States, Seattle

Description

Discovery Park Ventures uses Nordic culture and makes primary and secondary investments in venture capital fund funds.

Investor Profile

Discovery Park Ventures has backed more than 2 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 0 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Seed, Pre Seed rounds (top funding stages).
  • Majority of deals are located in United Kingdom.
  • Strong thematic focus on Health Care, Clinical Trials, Medical.

Stage Focus

  • Seed (50%)
  • Pre Seed (50%)

Country Focus

  • United Kingdom (100%)

Industry Focus

  • Health Care
  • Clinical Trials
  • Medical
  • Therapeutics
  • Artificial Intelligence (Ai)
  • Biotechnology
  • Life Science
  • Pharmaceutical
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Discovery Park Ventures frequently co-invest with?

Pioneer Group
Europe, England, United Kingdom, London
Co-Investments: 1
Sustainable Ventures
Europe, England, United Kingdom, London
Co-Investments: 1
Deep Science Ventures
Europe, England, United Kingdom, London
Co-Investments: 1
Cancer Research Horizons
Europe, England, United Kingdom, London
Co-Investments: 1
2048 Ventures
North America, New York, United States, New York
Co-Investments: 1

What are some of recent deals done by Discovery Park Ventures?

Neobe Therapeutics

London, England, United Kingdom

Neobe Therapeutics provides immunotherapies, clinical trials, research, and tumor-colonizing bacteria engineering services.

Clinical TrialsHealth CareMedicalTherapeutics
SeedFeb 29, 2024
Amount Raised: $2,340,000
Ignota Labs

London, England, United Kingdom

Ignota Labs recognizes that safety errors during the drug discovery process.

Artificial Intelligence (AI)BiotechnologyHealth CareLife SciencePharmaceutical
Pre SeedOct 11, 2022
0